China Biologic Products, Inc. (CBPO) Given $131.67 Consensus Target Price by Brokerages


Oberweis Asset Management Inc decreased China Biologic Products (CBPO) stake by 91.52% reported in 2017Q2 SEC filing. The stock recorded a fall in short interest of -5.23% as of the latest report on September 15, 2017. Agf invested in 163,920 shares or 0.21% of the stock. The firm has "Buy" rating by Jefferies given on Monday, June 12. (NASDAQ:ADSK) earned "Outperform" rating by Cowen & Co on Friday, August 25.

A number of large investors have recently bought and sold shares of CBPO. Jennison Associate Limited Liability invested in 0% or 5,775 shares. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories. (NASDAQ:WETF) rating on Friday, July 28.

Bellecapital International Ltd. holds 4.65% of its portfolio in Cooper Companies Inc for 22,174 shares.

03/03/2017 - China Biologic Products, Inc. had its "overweight" rating reiterated by analysts at Morgan Stanley. Industries Capital Prns Ltd Liability Com has 278,407 shares. Fil Limited has invested 0.28% in China Biologic Products Holdings, Inc. Northland Capital has "Hold" rating and $10.5000 target. The firm has "Neutral" rating by Northcoast given on Friday, January 29.

07/05/2016 - China Biologic Products, Inc. was upgraded to "outperform" by analysts at Credit Suisse. The rating was downgraded by Goldman Sachs on Wednesday, August 5 to "Buy". Invesco Limited holds 2.09 million shares.

Since May 8, 2017, it had 0 buys, and 1 insider sale for $873,638 activity. The firm has "Sell" rating given on Wednesday, August 26 by Citigroup. Vaughan Nelson Investment Management L.P., a Texas-based fund reported 2.30 million shares.

Investors sentiment decreased to 0.94 in Q2 2017. In the last earnings report the EPS was $3.84 and is projected to be $4.95 for the current year with 27,238,000 shares outstanding. Illinois-based Blair William & Co Il has invested 0.01% in Autodesk, Inc. Castine Capital Management Llc owns 240,051 shares or 4.33% of their U.S. portfolio. As of the end of the quarter Cubist Systematic Strategies, LLC had sold 2,494 shares trimming its stake by 48.3%. (NASDAQ:CBPO). Davidson Kempner Cap Management Lp reported 110,000 shares or 0.29% of all its holdings. Toronto Dominion Bank holds 65,779 shares. (NASDAQ:ADSK) for 3,646 shares. Prudential owns 4,280 shares. (NASDAQ:CBPO) shares were sold by Liu Zhijing CBPO. Northland Capital downgraded the stock to "Market Perform" rating in Wednesday, June 1 report. They expect $-0.33 earnings per share, up 23.26% or $0.10 from last year's $-0.43 per share. (NASDAQ:CBPO) to report earnings on November, 1. Momo Inc. Adr was raised too. (NASDAQ:CBPO) to report $1.30 EPS on November, 1.They anticipate $0.29 EPS change or 28.71% from last quarter's $1.01 EPS.

Analysts expect China Biologic Products Holdings, Inc. CBPO's profit will be $36.29M for 18.74 P/E if the $1.30 EPS becomes a reality. Its down 0.37, from 1.02 in 2017Q1. State Street Corporation holds 0% or 219,915 shares. Tiaa Cref Invest Mgmt Lc reported 0% stake. 41,858 were accumulated by Altrinsic Ltd Liability Co.

09/03/2014 - China Biologic Products, Inc. had its "buy" rating reiterated by analysts at Aegis Capital. Finally, First Trust Advisors LP boosted its position in shares of China Biologic Products by 35.9% during the first quarter. AHL Partners LLP acquired a new position in shares of China Biologic Products during the second quarter worth about $842,000. (NASDAQ:CBPO). Thomas White Limited stated it has 2.03% of its portfolio in China Biologic Products Holdings, Inc. Heartland Inc holds 200,000 shares. Dupont Capital Mngmt Corp invested 0.01% of its portfolio in Federated National Holding Co (NASDAQ:FNHC).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.